Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Deepak K. Lachhwani, MBBS, MD, is Staff Pediatric Epileptologist at the Epilepsy Center within the Neurological Institute of Cleveland Clinic, Cleveland, OH. Dr. Lachhwani is a member of the American Epilepsy Society (AES), Editor of AES News, and a committee member for the International League Against Epilepsy. He is very active in the American Academy of Neurology and serves on the editorial board of CNP News. He is also a member of the Child Neurology Society, American Society of Neuroimaging and the Society of Nuclear Medicine.
Dr. Lachhwani’s particular interests lie in treating children with medically refractory epilepsy, functional neuroimaging, pediatric epilepsy surgery and ICU monitoring of neonates and children. His research interests revolve around these fields, with specific reference to clinical outcomes after epilepsy surgery in children with tuberous sclerosis, Stroke, Rasmussen’s encephalitis and medically refractory status epilepticus. He expands the sphere of medical care at Cleveland Clinic provided to children with seizures by directing the activities of the Pediatric Epilepsy Support Group, which offers a unique platform for educating and supporting families of these children.
Dr. Lachhwani gained an MD from the Gandhi Medical College at Bhopal, India, in 1991 and completed his Pediatric residency and Neurology residency training at the Mayo Clinic Graduate School of Medicine in Rochester, Minn. He then completed his subspecialty training in Pediatric Epilepsy at Cleveland Clinic and accepted his current professional staff position.
Dr. Lachhwani is an avid writer for several peer-reviewed publications, has published several book chapters, and has presented numerous posters at national and international meetings. He has co-edited the fourth edition of the textbook, “The Treatment of Epilepsy: Principles and Practice.” He was awarded the Junior Resident Travel Award from the Department of Pediatrics at Mayo Clinic in 1994, was a high honors student at the Gandhi Medical College, Bhopal, India (1983-1991), and earned a Distinguished Services Award for patient care during the Union Carbide methyl-isocyanate (MIC) gas tragedy at Bhopal (December 1984).
children with complex epilepsies, children with epilepsy and Sturge Weber Syndrome, children with first seizure, clinical drug trials, clinical neurophysiology, diagnostic video EEG for pediatric seizure disorders, EEG, Epilepsy, epilepsy and epilepsy surgery in children and adolescents, Epilepsy surgery and medical treatment of epilepsy in children, interpretation of continuous EEG monitoring in the critical care setting, invasive EEG monitoring for pre-surgical evaluations, Pediatric Epilepsy, pediatric epilepsy and epilepsy surgery, Rasmussen's encephalitis and medically refractory status epilepticus., Seizure disorder treatment and surgery in brain malformations, seizure manifestations, Sturge Weber syndrome, surgical treatment of refractory epilepsy and functional imaging, Tuberous Sclerosis Complex, vagus nerve stimulation, Video EEG, clinical outcomes after epilepsy surgery in children with tuberous sclerosis
Awards & Honors
Distinguished Services Award for patient care during the Union Carbide MIC gas tragedy at Bhopal, India, December 1984 ---
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/15/2017, Dr. Lachhwani has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.